Xanirva

Xanirva (rivaroxaban) is an oral anticoagulant used to help prevent blood clots. It belongs to a class of medications that work by blocking certain clotting proteins. This medication is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Xanirva is commonly prescribed to reduce the risk of blood clots forming in the body. It is often used in patients with atrial fibrillation to prevent strokes and systemic embolism. The medication may also be used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to help prevent these conditions from recurring after initial treatment.

Xanirva works by inhibiting a specific clotting factor in the blood, which helps prevent the formation of dangerous blood clots. Patients may notice improved blood flow and reduced risk of clot-related complications over time. The effects of the medication are not immediately felt, as it works gradually to support the body's natural anticoagulant processes.

Xanirva should be taken exactly as prescribed by a healthcare provider to minimize risks. It is important to inform your doctor about any bleeding disorders, liver or kidney problems, or other medications you are taking. Regular monitoring may be required to ensure the medication is working safely and effectively.

Xanirva can interact with other medications that affect blood clotting or are metabolized by the liver. Common interacting substances include certain antibiotics, antifungals, and other anticoagulants. Alcohol and herbal supplements, such as St. John’s wort, may also alter the medication’s effects. Always consult a healthcare provider before combining medications.